Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays.

Cancer Cell International
Tao Yan-FangPan Jian


The Real-time PCR Array System is the ideal tool for analyzing the expression of a focused panel of genes. In this study, we will analyze the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays. Real-time PCR array was designed and tested firstly. Then gene expression profile of 11 pediatric AML and 10 normal controls was analyzed with real-time PCR arrays. We analyzed the expression data with MEV (Multi Experiment View) cluster software. Datasets representing genes with altered expression profile derived from cluster analyses were imported into the Ingenuity Pathway Analysis Tool. We designed and tested 88 real-time PCR primer pairs for a quantitative gene expression analysis of key genes involved in pediatric AML. The gene expression profile of pediatric AML is significantly different from normal control; there are 19 genes up-regulated and 25 genes down-regulated in pediatric AML. To investigate possible biological interactions of differently regulated genes, datasets representing genes with altered expression profile were imported into the Ingenuity Pathway Analysis Tool. The results revealed 12 significant networks. Of these networks, Cellular Development, Cellular Growth and Proliferatio...Continue Reading


Feb 5, 2000·Medical and Pediatric Oncology·B GustafssonJ Winiarski
Feb 5, 2000·Medical and Pediatric Oncology·A C KattamisF Tzortzatou-Stathopoulou
Mar 7, 2002·Journal of Pediatric Hematology/oncology·J GumpS P Hunger
Apr 27, 2002·Nature·Diane Gershon
Jul 12, 2002·Genetic Epidemiology·Richard SimonKevin Dobbin
Nov 20, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L Pusztai, K R Hess
Feb 3, 2005·Cancer Biology & Therapy·Raffaele AddeoPaolo Indolfi
May 11, 2005·Folia Microbiologica·T MajtánJ Timko
Apr 6, 2006·The Journal of Biological Chemistry·Ningxi ZhuMuxiang Zhou
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel SteinbachBernd Gruhn
Nov 28, 2006·Lancet·Elihu Estey, Hartmut Döhner
Feb 9, 2007·Molecular Diagnosis & Therapy·Sung-Min ChunByoung-Don Han
Apr 4, 2007·The Journal of Clinical Investigation·Kim L Rice, Jonathan D Licht
Aug 13, 2008·Methods in Molecular Biology·Thomas D SchmittgenJinmai Jiang
Jan 22, 2009·Médecine sciences : M/S·Olivier BoucheratLucie Jeannotte
Jul 1, 2009·European Journal of Haematology·Mike ZangenbergPeter Hokland
Oct 31, 2009·BMC Medical Genomics·Xiaosheng Wang, Osamu Gotoh
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Silvia BresolinGiuseppe Basso
Oct 5, 2010·The Korean journal of laboratory medicine·Shine Young KimEun Yup Lee

❮ Previous
Next ❯


Oct 24, 2013·Cancer Cell International·Marina PetriniAlessandra Carè
Feb 9, 2016·BJOG : an International Journal of Obstetrics and Gynaecology·V C SandrimR C Cavalli
Jan 23, 2015·Journal of Experimental & Clinical Cancer Research : CR·Yan-Fang TaoJian Pan
Oct 7, 2016·Cell Death & Disease·Kit I TongHitoshi Okada
Apr 25, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Christos K KontosAthanasios G Papavassiliou
May 27, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Martha L SlatteryJennifer S Herrick
Jan 22, 2021·European Journal of Pharmacology·Han LiuXiao-Ping Chen

❮ Previous
Next ❯

Methods Mentioned


Software Mentioned

MEV ( Multi Experiment View )
Ingenuity Pathway Analysis Tool

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Toxicology and Applied Pharmacology
E W SchaferD J Cunningham
Proceedings of the National Academy of Sciences of the United States of America
Mats H HolmqvistW F An
The Journal of Emergency Medicine
Nicholas C Johnson, Matthew W Morgan
© 2022 Meta ULC. All rights reserved